soul trial oral semaglutide cardiovascular outcomes 2025 A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link soul trial oral semaglutide cardiovascular

It also helps your metabolic health and can lead to the best weight management with fewer side effects

The BBD data were analyzed using contour and 3D plots to elucidate the independent variables' effects

If Medicaid coverage is delayed, denied, or limited in your state, understanding your genetic and biomarker context can support a more targeted discussion with your provider about alternative therapies, dosing strategies, and whether compounded GLP-1 optionsavailable through PlexusDx at affordable monthly ratesmay be appropriate for your clinical situation

Your care team can help you weigh comfort, expected results, and long-term consistency